Home » Topics » BioWorld Science

BioWorld Science
RSS

AbbVie licenses Lupin's MALT1 inhibitor program

Dec. 27, 2018

Mitophagy findings may offer new PD treatment promise

Dec. 27, 2018

TRACON Pharmaceuticals submits IND application for TJ-4309

Dec. 27, 2018

MEI Pharma initiates phase II study of ME-401 in follicular lymphoma

Dec. 27, 2018

Shenzhen Salubris Pharmaceuticals describes DPP-IV inhibitors for diabetes

Dec. 27, 2018

NantBioScience reports high-affinity nerve growth factor receptor inhibitors

Dec. 27, 2018

Oryzon patents lysine-specific demethylase inhibitors

Dec. 27, 2018

New LAG-3 ligand identified

Dec. 27, 2018

ASO for LCA

Dec. 27, 2018

Tumor-targeted trimeric 4-1BB-agonistic antibody 1D8N/CEGa1 shows safety and efficacy in vivo

Dec. 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...